Cositecan for treating platinum or taxane resistant advanced, mucinous, epithelial ovarian cancer [ID826]

  • In development
  • GID-TA10446
  • Expected publication date: TBC

Status:
In progress
Decision:
Selected
Process:
TA

Timeline

Key events during the development of the guidance:

Date Update
05 December 2017 In progress. Topic referred

For further information on our processes and methods, please see our CHTE processes and methods manual